NGVT Stock Recent News
NGVT LATEST HEADLINES
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity releases 2023 sustainability report highlighting its commitment to actions and product innovations that enable a more sustainable world.
Ingevity Corporation (NYSE:NGVT ) Q1 2024 Earnings Conference Call May 2, 2024 10:00 AM ET Company Participants John Nypaver - Vice President of Investor Relations & Treasurer John Fortson - President & Chief Executive Officer Mary Hall - Chief Financial Officer Rich White - President, Performance Chemicals Ed Woodcock - President, Performance Materials Conference Call Participants Vincent Anderson - Stifel Daniel Rizzo - Jefferies John McNulty - BMO Capital Markets Ian Zaffino - Oppenheimer Jon Tanwanteng - CJS Securities Mike Sison - Wells Fargo Chris Kapsch - Loop Capital Markets Operator Good morning or good afternoon. Welcome to the Ingevity First Quarter 2024 Earnings Webcast.
The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.
While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ingevity (NGVT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $1.09 per share a year ago.
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that it will release its first-quarter 2024 earnings after the stock market close on Wednesday, May 1, 2024.
Ingevity (NGVT) sees strong results in the Performance Materials segment and the Road Technologies business line in Q4.
The headline numbers for Ingevity (NGVT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ingevity (NGVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to earnings of $0.57 per share a year ago.
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?